Vertex Pharmaceuticals (VRTX) Treasury Shares (2010 - 2026)

Vertex Pharmaceuticals' Treasury Shares history runs 17 years deep, the most recent figure standing at $700000.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 22.22% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $700000.0 (down 22.22% YoY), while the FY2025 annual figure was $4.8 million, up 77.78% from the prior year.
• Treasury Shares was $700000.0 for Q1 2026 at Vertex Pharmaceuticals, down from $4.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.8 million in Q4 2025 to a low of $300000.0 in Q1 2024.
• Historically, Treasury Shares has averaged $1.6 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares plunged 60.1% in 2022, then surged 200.0% in 2025.
• A 5-year view of Treasury Shares shows it stood at $2.9 million in 2022, then sank by 55.37% to $1.3 million in 2023, then surged by 107.69% to $2.7 million in 2024, then surged by 77.78% to $4.8 million in 2025, then tumbled by 85.42% to $700000.0 in 2026.
• The last three Treasury Shares figures came in at $700000.0 (Q1 2026), $4.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.